Routine

Daily sedation interruption & RASS-targeted sedation

Sedation · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A sedation strategy that uses a validated scale (the Richmond Agitation-Sedation Scale) to target light sedation, with daily sedation interruption and spontaneous breathing trials, to shorten ventilation and ICU stay.

Red flags

  • Deep sedation (with or without neuromuscular blockade) still required in severe ARDS, raised ICP, status epilepticus or severe dyssynchrony — defer the sedation hold
  • Agitation causing self-extubation or line removal (under-sedation)

Assessment

Investigations

  • RASS score and CAM-ICU delirium screen
  • Readiness-to-wean / spontaneous-breathing-trial parameters

Management

  • Set a target RASS (usually 0 to -2) unless deep sedation is clinically required
  • Treat pain first — analgesia-based sedation
  • Perform a daily sedation hold / awakening trial, paired with a spontaneous breathing trial where safe
  • Screen for delirium (CAM-ICU) and minimise benzodiazepines
  • Mobilise early once awake and stable

Drugs & doses

Analgesia-first approach; propofol or dexmedetomidine preferred over benzodiazepines

Disposition

Protocolised ICU sedation with daily review of depth and weaning readiness.

Complications & pitfalls

  • Over-sedation: prolonged ventilation, delirium, VAP, weakness, hypotension
  • Under-sedation: agitation, self-extubation, ventilator dyssynchrony

Exam pearls

  • Analgesia first, then the lightest sedation that is safe
  • Pair the daily awakening with a spontaneous breathing trial
  • Avoid benzodiazepines where possible — they drive delirium

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.